Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Reversible Cerebral Vasoconstriction SyndromeVaricella-zoster Virus Infection
Interventions
DIAGNOSTIC_TEST

VZV-specific antibody response from blood

Check VZV-specific antibody response, VZV specific T-cell mediated immune response by IFN-γ ELISPOT assay from blood, and real-time PCR results from saliva

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanyang University

OTHER

collaborator

Eulji University Hospital

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

lead

Asan Medical Center

OTHER

NCT03509701 - Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus | Biotech Hunter | Biotech Hunter